Andrew E. Hendifar, MD
Medical Director, Pancreatic Cancer
Assistant Professor, Medicine
Clinical Office 1
Samuel Oschin Cancer Center
127 S San Vicente Blvd - 7th Floor
Los Angeles, CA
90048
Phone:
310-423-2217
Fax:
310-967-8486
Clinical Office 2
Pancreatic Cancer Screening and Early Detection Program
8720 Beverly Blvd, Lower Level
Los Angeles, CA
90048
Phone:
310-423-6082
Fax:
310-423-1826
Andrew E. Hendifar, MD
Medical Director, Pancreatic Cancer
Assistant Professor, Medicine
Specialty
- IM/Hematology/Oncology
Research Profile
The current research focus of Andrew Hendifar, MD, is on developing new therapies for pancreatic cancer and neuroendocrine tumors. Dr. Hendifar has helped form multidisciplinary teams that specialize in the treatments of pancreatic cancer, and carcinoid and neuroendocrine tumors. Dr. Hendifar is the primary investigator for several groundbreaking therapies, including radioimmunotherapy for neuroendocrine tumors, anti-inflammatory therapy for pancreatic cancer and novel approaches to cancer cachexia. His national roles include SWOG GI Committee Member and a member of NIH Neuroendocrine Tumor Task Force. He also serves on the steering committee member for the Precision Promise Consortium and chairs the associated Supportive Care Committee. At Cedars Sinai he leads the Gastrointestinal Disease Research Group and is the founding Director of the Hematology and Oncology Fellowship Program.
Education
- Medical School: Tulane University School of Medicine, 2003
- Internship: Los Angeles County + USC Medical Center, 2006
- Residency: Los Angeles County + USC Medical Center, 2007
- Fellowship: University of Southern California, 2010
Languages Spoken
English / Spanish
Make an Appointment